Skip to main content

Jessica Fee

Analyst

J.P. Morgan

Equibles does not estimate personal net worth.

About Jessica Fee

Jessica Fee is recorded as Analyst at J.P. Morgan. Jessica Fee has spoken on 1 earnings call across 1 company, most recently for Ionis Pharmaceuticals Inc on April 29, 2026. The companies whose calls Jessica Fee spoke on are classified in the Healthcare sector.

Jessica Fee on recent calls

“So, you once again raised peak expectations for Tringolza. Can you just spend a little time elaborating on what enabled you to increase it from at least $2 billion at J.P. Morgan to now at least $3 billion?”
Analyst — J.P. Morgan, Ionis Pharmaceuticals Inc Q1 FY2026 Earnings Call ·

Affiliation history

  • J.P. Morgan

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity